Maqui berry extract: What's the best dose for your blood vessels?
NCT ID NCT07196059
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study tested three different doses of a maqui berry extract called Delphinol in 10 healthy adults to see how it affects blood vessel function. Participants took each dose for 8 days, and researchers measured blood flow and related markers. The goal was to find the optimal dose for future research, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Maqui berry extract (Delphinol)
- What this could lead to
- If successful, this could help identify the best dose of maqui berry extract for improving blood vessel function in future studies.
- What could go wrong
- This is a very small, early study in only 10 healthy people. Results may not apply to others, and the supplement may show no clear benefit at any dose.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Center for Nutraceutical and Dietary Supplement Research
Memphis, Tennessee, 38152, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test